1-4 of 4
Simona Paratore
Close
Sort by
Journal Articles

Analysis of Bone Marrow Microenviroment Factors As Early Markers of Response in Patients with Newly Diagnosed Bcr-Abl Positive CML in Chronic Phase Treated with Nilotinib.

Concetta Quintarelli, PhD, Biagio De Angelis, PhD, Santa Errichiello, PhD, Simona Caruso, Nicola Esposito, PhD, Luigia Luciano, MD, Simona Paratore, PhD, Claudia Galimberti, PhD, Simona Soverini, PhD, Carolina Terragna, PhD, Daniela Cilloni, MD, Giuseppe Saglio, MD, Giovanni Martinelli, Frank Giles, MD, Andreas Hochhaus, MD, Fabrizio Pane
Journal: Blood
Blood (2012) 120 (21): 2795.
https://doi.org/10.1182/blood.V120.21.2795.2795
Published: 2012
Journal Articles

Safety and efficacy of everolimus, a mTOR inhibitor, as single agent in a phase 1/2 study in patients with myelofibrosis

Clinical Trials & Observations
Paola Guglielmelli, Giovanni Barosi, Alessandro Rambaldi, Roberto Marchioli, Arianna Masciulli, Lorenzo Tozzi, Flavia Biamonte, Niccolò Bartalucci, Elisabetta Gattoni, Maria Letizia Lupo, Guido Finazzi, Alessandro Pancrazzi, Elisabetta Antonioli, Maria Chiara Susini, Lisa Pieri, Elisa Malevolti, Emilio Usala, Ubaldo Occhini, Alberto Grossi, Silvia Caglio, Simona Paratore, Alberto Bosi, Tiziano Barbui, Alessandro M. Vannucchi, on behalf of the AIRC-Gruppo Italiano Malattie Mieloproliferative (AGIMM) investigators
Journal: Blood
Blood (2011) 118 (8): 2069–2076.
https://doi.org/10.1182/blood-2011-01-330563
Published: 2011
Includes: Supplemental data
Journal Articles

A Phase 1/2 Study of RAD001, a mTOR Inhibitor, In Patients with Myelofibrosis: Final Results

Alessandro M. Vannucchi, MD, Paola Guglielmelli, MD, Letizia Lupo, MD, Maria Chiara Finazzi, MD, Lorenzo Tozzi, BiSc, Flavia Biamonte, BiSc, Arianna Masciulli, MD, Maria Chiara Susini, MD, Alessandro Pancrazzi, BiSc, Guido Finazzi, MD, Simona Paratore, MD, Roberto Marchioli, Alberto Bosi, Tiziano Barbui, MD, Alessandro Rambaldi, MD, Giovanni Barosi, MD
Journal: Blood
Blood (2010) 116 (21): 314.
https://doi.org/10.1182/blood.V116.21.314.314
Published: 2010
Journal Articles

Transient Massive Lymphoid Bone Marrow Infiltrate Developing during Therapy with the Tyrosine Kinase Inhibitors Imatinib and Nilotinib: Report of 2 Patients.

Ester Pungolino, MD, Silvia Cantoni, MD, Cecilia Del Curto, MD, Livio Gargantini, MD, Marianna Caramella, MD, Sara Miqueleiz, MD, Alessandra Tedeschi, MD, Michela Draisci, MD, Cristina Gabutti, MD, Simona Paratore, MD, Karen Lanza, BD, Sonia Ribera, MD, Enrica Morra, MD
Journal: Blood
Blood (2007) 110 (11): 4577.
https://doi.org/10.1182/blood.V110.11.4577.4577
Published: 2007